Prevalence of non albicans candida species in a tertiary care hospital

---

Original Article

Author Details : Y Raja Ratna Reddy, M Nissi Priya*, B Ramachandra Reddy, Manisha Singh, Vasanti Kabra

Volume : 6, Issue : 3, Year : 2019

Article Page : 277-279

https://doi.org/10.18231/j.ijmr.2019.060

Suggest article by email

Get Permission

---

Abstract

Introduction: Candida species are recognized as the most important fungal pathogens with significant
contribution to the morbidity and mortality in critically ill patients. C. albicans is the leading cause of fungal
infections until the recent emergence of non albicans Candida (NAC) infections, therefore transforming the
current epidemiological trends.
Materials and Methods: The clinical samples received in the microbiology department were cultured
on Sabouraud ’ s dextrose agar followed by identification and sensitivity testing of Candida species using
automated VITEK 2-compact (biomerieux) instrument.
Results and Discussion: The present study also shows the prevalence of NAC species with C. utilis
being the most significant isolate from neonatal blood cultures. C. utilis is generally considered as an
industrial yeast with low virulence, hence occasionally reported from clinical samples. However, their
clinical relevance should be interpreted with strong clinical and microbiological correlation.
Conclusion: Surveillance for emerging fungal pathogens is essential to monitor the changing
epidemiological trends for controlling the spread of NAC species

Keywords: Non albicans Candida, Candida utilis, Fungemia, Virulence.

How to cite : Reddy Y R R, Priya M N, Reddy B R, Singh M, Kabra V, Prevalence of non albicans candida species in a tertiary care hospital. Indian J Microbiol Res 2019;6(3):277-279

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.